文献速递免疫规划

高产悬浮MDCK细胞用于先进甲型流感病毒扩增的多特征潜力揭示

Unveiling the multi-characteristic potential of hyper-productive suspension MDCK cells for advanced influenza A virus propagation.
PubMed 文献 · Vaccine · 2025-02-21

研究比较了高代次悬浮MDCK细胞(MDCK-HG)与原始悬浮MDCK细胞在多种操作条件下生产流感病毒的能力,发现MDCK-HG对H9N2株最大血凝效价达15.02 Log2HAU/100 μL、对H1N1株达12.55 Log2HAU/100 μL,较原始细胞分别提高56.95%和189.79%,并通过动力学、转录组和代谢分析揭示细胞周期重分布、抗凋亡增强、膜合成速率升高和能量代谢高效可能贡献其产能提升。

要点

  • MDCK-HG对H9N2株最大血凝效价为15.02 Log2HAU/100 μL,较原始悬浮MDCK细胞提高56.95%。
  • MDCK-HG对H1N1株最大血凝效价为12.55 Log2HAU/100 μL,较原始悬浮MDCK细胞提高189.79%。
  • 细胞周期重分布、抗凋亡能力增强、膜合成速率升高和能量代谢高效可能贡献MDCK-HG的病毒产能提升。

核心结论

  • MDCK-HG细胞在多种操作条件下表现出增强的流感病毒产能,其机制可能涉及细胞周期重分布、抗凋亡能力增强、膜合成速率升高和能量代谢高效。

研究设计与样本

  • 研究比较高代次悬浮MDCK细胞系(MDCK-HG)与原始悬浮MDCK细胞在多种操作条件下生产流感病毒的能力,并结合动力学分析、转录组分析和代谢特征分析。

主要发现

  • MDCK-HG对H9N2株最大血凝效价为15.02 Log2HAU/100 μL,较原始悬浮MDCK细胞提高56.95%。
  • MDCK-HG对H1N1株最大血凝效价为12.55 Log2HAU/100 μL,较原始悬浮MDCK细胞提高189.79%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The global population faces persistent threats from influenza viruses, with vaccination remaining the most cost-effective preventive measure against influenza. Mammalian cell-based influenza vaccine production has garnered significant attention due to its enhanced safety profile, process controllability, and ability to circumvent adaptive mutations commonly associated with traditional egg-based vaccines, and the particular promise of suspension cell-based production systems for their convenience, economic viability, and scalability potential. Despite years of development and an increasing number of approved animal substrate-based vaccines, numerous challenges persist, especially the incomplete understanding of influenza virus amplification features in the producing cell lines. In previous research, we developed a high-titer suspension MDCK cell-based influenza virus production process and established a high-generation MDCK cell line (MDCK-HG). This study demonstrated enhanced productive capacity of MDCK-HG cells across diverse operational conditions. The maximum hemagglutination titer achieved 15.02 Log2HAU/100 μL for H9N2 strain and 12.55 Log2HAU/100 μL for H1N1 strain, which evidenced by a 56.95 % and a 189.79 % increase compared to the original suspension MDCK cells. Through kinetics analyses, transcriptomic profiling, and metabolic characterization, we identified the kinetic features of high-generation cell lines for efficient influenza virus production and discovered that the redistribution of cell cycles, enhanced anti-apoptotic capabilities, elevated membrane synthesis rates, and efficient energy metabolism likely contribute to their increased viral production capacity. These findings not only deepen our understanding of the influenza vaccine production process but also provide valuable guidance for future systematic metabolic engineering efforts aimed at establishing more robust vaccine production processes.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ye Q, Xiao Z, Bai C, et al. Unveiling the multi-characteristic potential of hyper-productive suspension MDCK cells for advanced influenza A virus propagation. Vaccine. 2025. PMID: 39985968. doi:10.1016/j.vaccine.2025.126900

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。